It has been suggested that patients with NAFLD have lower concentrations of biologically active incretin hormones compared to healthy individuals, which may be a consequence of an increased degradation by dipeptidyl peptidase 4 (DPP-4) (the enzyme, which under normal conditions inactivates the incretin hormones) (29) or a decreased production (30, 31)
Half-life comparison across GLP-1 medications Different GLP-1 medications have different pharmacokinetic profiles
The proportion of otologic AEs was 958 (0.99%): 515 hypoacusis, 203 vertigo, 97 deafness, 93 tinnitus, 22 ear pain, 21 motion sickness, 5 hyperacusis, 2 ear fullness, and 0 autophony
It is recommended to use standard doses and avoid exceeding safe upper limits
Injection, however, is becoming increasingly popular due to its superior absorption rate and more direct impact
Free-floating intestinal rings were stained with primary antibodies against RFP and GLP-1 (See Table 1) diluted in 0.1% Triton X-100 in PBS (pH 7.4)